CYTH - Cyclo Therapeutics GAAP EPS of -$0.59 revenue of $186.8M March, 20 2023 08:58 AM Cyclo Therapeutics Inc. 2023-03-20 08:58:31 ET Cyclo Therapeutics press release ( NASDAQ: CYTH ): Q4 GAAP EPS of -$0.59. Revenue of $186.8M. For further details see: Cyclo Therapeutics GAAP EPS of -$0.59, revenue of $186.8M